Sigh35 and End-expiratory Occlusion Test (EEOT) for Assessing flUid Responsiveness in Critically Ill Patients Undergoing Pressure Support Ventilation (SETUP)
Primary Purpose
Critically Ill Patients, Hemodynamic Instability, Mechanical Ventilation Pressure High
Status
Recruiting
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
SIGH
EEOT
Sponsored by
About this trial
This is an interventional diagnostic trial for Critically Ill Patients
Eligibility Criteria
- Adult (>18 yo) ICU patients undergoing PSV ventilation
- Inspiratory support level (PS) between 8 and 15 cmH2O and positive end-expiratory pressure (PEEP) between 5 and 12 cmH2O,
Presence of acute circulatory failure defined as:
- Systolic blood pressure (SBP) ≤90 mmHg or mean arterial pressure (MAP) ≤70 mmHg or requiring vasopressors to maintain SBP >90 mmHg or MAP >70 mmHg or decline of SBP > 50 mm Hg in known hypertensive patients, along with one or more of the following:
- urinary flow ≤0.5 mL/kg/min for ≥2 hours
- heart rate ≥100 beats per minute
- presence of skin mottling and 4) blood lactate concentration ≥4 mmol/L.
Exclusion criteria
- left ventricular ejection fraction <30% or severe valvular dysfunction
- atrial fibrillation
- severe acute respiratory distress syndrome (ARDS)
- abdominal compartment syndrome
- air leakage through chest drains
- artifacts in arterial waveform
- pathological respiratory patterns due to neurological diseases
- signs of fatigue or respiratory distress
Sites / Locations
- Humanitas Research HospitalRecruiting
- Humanitas Research HospitalRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Intervention EEO_SIGH
Arm Description
Single arm intervention. All the patients will receive the two tests (SIGH and EEOT) in 1:1 random sequence order (6 patient-block)
Outcomes
Primary Outcome Measures
Pulse pressure prediction of fluid responsiveness
Pulse pressure changes after SIGH35 application
Stroke volume prediction of fluid responsiveness
Stroke Volume changes after SIGH35 application
Secondary Outcome Measures
Pulse pressure prediction of fluid responsiveness
Pulse pressure changes after EEOT application
Stroke volume prediction of fluid responsiveness
Stroke Volume changes after EEOT application
Full Information
NCT ID
NCT04924920
First Posted
June 4, 2021
Last Updated
March 13, 2023
Sponsor
Humanitas Clinical and Research Center
1. Study Identification
Unique Protocol Identification Number
NCT04924920
Brief Title
Sigh35 and End-expiratory Occlusion Test (EEOT) for Assessing flUid Responsiveness in Critically Ill Patients Undergoing Pressure Support Ventilation
Acronym
SETUP
Official Title
Sigh35 and End-expiratory Occlusion Test (EEOT) for Assessing flUid Responsiveness in Critically Ill Patients Undergoing Pressure Support Ventilation
Study Type
Interventional
2. Study Status
Record Verification Date
March 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 1, 2022 (Actual)
Primary Completion Date
October 1, 2023 (Anticipated)
Study Completion Date
October 1, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Humanitas Clinical and Research Center
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The application of a brief SIGH of 4 seconds at 35 cmH20 has shown to reliably predict fluid responsiveness in critically ill patients undergoing pressure support ventilation.
The end-expiratory occlusion test (EEOT) has been also used in the same type of patients, with the same purpose, but in a limited amount of studies.
The aim of this study is to compare the reliability of the the two test in assessing fluid responsiveness.
Detailed Description
Assessing preload dependence in critically ill patients is a challenge for the Intensive Care Unit (ICU) physicians. During controlled mechanical ventilation, dynamic indexes can be applied in non-arrhythmic patients with sufficiently high tidal volume (VT), i.e., >8 ml/kg and non-severely impaired lung compliance. The interplay between mechanical ventilation and hemodynamic is more complex in patients with a spontaneous breathing activity, whose respiratory efforts affect intrathoracic pressure and venous return to the right ventricle (RV).
To overcome these limitations, functional hemodynamic assessment, consisting in maneuvers determining a sudden change in cardiac preload, such as Passive leg raising (PLR) or end-expiratory occlusion test (EEO), represents a valuable means for assessment of fluid responsiveness.
Both PLR and EEO have been successfully utilized for assessing fluid responsiveness, regardless of ventilatory assistance and mode of ventilation. Unfortunately, however, some drawbacks limit the extensive use of these maneuvers in clinical practice. One the one hand, PLR cannot be applied in some clinical situations, such as traumatisms of the hip, legs or lumbar spine, deep venous thrombosis, intracranial or abdominal hypertension. Indeed, a recent large observational study showed PLR to be the most common form of assessment of fluid responsiveness, being used, nonetheless, in only 10.7% of the patients necessitating the assessment of fluid responsiveness. On the other hand, rates of EEO failure as high as 22.5 % have been reported, consequent to visible patient's effort against the occluded airway.
It has been recently successfully tested a new approach for assessing fluid responsiveness in patients undergoing partial ventilatory assistance. It has been proposed that the changes from baseline of systolic arterial pressure (SAP), pulse pressure (PP) and stroke volume index (SVI) in relationship to the airway pressure (Paw) generated during a "sigh" maneuver can predict fluid responsiveness in ICU patients undergoing pressure support ventilation (PSV) In the first "proof of concept" study (performed in 40 hemodynamically unstable ICU patients) three sighs has been tested, in a computer-generated random order, at either 15 (SIGH15), 25 (SIGH25) and 35 (SIGH35) cmH2O of total inspiratory Paw (PEEP + PSV). The results showed that only the variation of the pulse pressure recorded after SIGH35 application successfully predicted fluid responsiveness. [AUC of PP after SIGH35 = 0.91 (0.82 - 0.99); sensitivity 75% (47.6%-92.7%) and specificity 91.6 (73.0%- 98.9%); best threshold value of the ROC curve was -35% from baseline].
Hemodynamic Measurements. All patients will be equipped with a continuous hemodynamic monitoring of arterial waveform
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Critically Ill Patients, Hemodynamic Instability, Mechanical Ventilation Pressure High
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Cross-over design. The study has one single arm cross-over treatment design. The same patient will be assessed by means of the two tests. The sequence of application will be randomly generated and applied to the patients.
Masking
None (Open Label)
Allocation
N/A
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Intervention EEO_SIGH
Arm Type
Experimental
Arm Description
Single arm intervention. All the patients will receive the two tests (SIGH and EEOT) in 1:1 random sequence order (6 patient-block)
Intervention Type
Diagnostic Test
Intervention Name(s)
SIGH
Intervention Description
To add the Sigh35 to PSV, the ventilator is set in pressure controlled synchronized intermittent mandatory ventilation plus PSV [SIMV (PC) + PS mode], with SIMV rate set a 1/min and inspiratory time of 4 seconds. SIMV (PC) = 35 cmH20 of total inspiratory support (PEEP + PS).
Intervention Type
Diagnostic Test
Intervention Name(s)
EEOT
Intervention Description
• The EEOT is performed by interrupting the mechanical ventilation for 15 seconds, by using and end-expiratory hold on the ventilator. The ventilator trigger is set at 2 L/min.
Primary Outcome Measure Information:
Title
Pulse pressure prediction of fluid responsiveness
Description
Pulse pressure changes after SIGH35 application
Time Frame
Evaluated before and after SIGH35 (within 1 minute from SIGH35 application)
Title
Stroke volume prediction of fluid responsiveness
Description
Stroke Volume changes after SIGH35 application
Time Frame
Evaluated before and after SIGH35 (within 1 minute from SIGH35 application)
Secondary Outcome Measure Information:
Title
Pulse pressure prediction of fluid responsiveness
Description
Pulse pressure changes after EEOT application
Time Frame
Evaluated before and after EEOT (within 1 minute from EEOT application)
Title
Stroke volume prediction of fluid responsiveness
Description
Stroke Volume changes after EEOT application
Time Frame
Evaluated before and after EEOT (within 1 minute from EEOT application)
Other Pre-specified Outcome Measures:
Title
Rate of failure of SIGH test
Description
Presence of cough
Time Frame
During the test execution
Title
Rate of failure of EEOT test
Description
Trigger of the ventilator
Time Frame
During the test execution
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Adult (>18 yo) ICU patients undergoing PSV ventilation
Inspiratory support level (PS) between 8 and 15 cmH2O and positive end-expiratory pressure (PEEP) between 5 and 12 cmH2O,
Presence of acute circulatory failure defined as:
Systolic blood pressure (SBP) ≤90 mmHg or mean arterial pressure (MAP) ≤70 mmHg or requiring vasopressors to maintain SBP >90 mmHg or MAP >70 mmHg or decline of SBP > 50 mm Hg in known hypertensive patients, along with one or more of the following:
urinary flow ≤0.5 mL/kg/min for ≥2 hours
heart rate ≥100 beats per minute
presence of skin mottling and 4) blood lactate concentration ≥4 mmol/L.
Exclusion criteria
left ventricular ejection fraction <30% or severe valvular dysfunction
atrial fibrillation
severe acute respiratory distress syndrome (ARDS)
abdominal compartment syndrome
air leakage through chest drains
artifacts in arterial waveform
pathological respiratory patterns due to neurological diseases
signs of fatigue or respiratory distress
Facility Information:
Facility Name
Humanitas Research Hospital
City
Rozzano
State/Province
Milano
ZIP/Postal Code
20089
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Antonio Messina, MD
Phone
+390282241
Email
antonio.messina@humanitas.it
First Name & Middle Initial & Last Name & Degree
Antonio Messina, MD
Phone
+3902822414131
Email
mess81rc@gmail.com
Facility Name
Humanitas Research Hospital
City
Rozzano
State/Province
Milano
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Antonio Messina, PhD
Phone
+390282241
Email
antonio.messina@humanitas.it
12. IPD Sharing Statement
Plan to Share IPD
Undecided
IPD Sharing Plan Description
The datasets used and/or analyzed during this study are available from the corresponding author on reasonable request.
Citations:
PubMed Identifier
30691523
Citation
Messina A, Colombo D, Barra FL, Cammarota G, De Mattei G, Longhini F, Romagnoli S, DellaCorte F, De Backer D, Cecconi M, Navalesi P. Sigh maneuver to enhance assessment of fluid responsiveness during pressure support ventilation. Crit Care. 2019 Jan 28;23(1):31. doi: 10.1186/s13054-018-2294-4.
Results Reference
background
PubMed Identifier
11964584
Citation
Patroniti N, Foti G, Cortinovis B, Maggioni E, Bigatello LM, Cereda M, Pesenti A. Sigh improves gas exchange and lung volume in patients with acute respiratory distress syndrome undergoing pressure support ventilation. Anesthesiology. 2002 Apr;96(4):788-94. doi: 10.1097/00000542-200204000-00004.
Results Reference
background
PubMed Identifier
19237902
Citation
Monnet X, Osman D, Ridel C, Lamia B, Richard C, Teboul JL. Predicting volume responsiveness by using the end-expiratory occlusion in mechanically ventilated intensive care unit patients. Crit Care Med. 2009 Mar;37(3):951-6. doi: 10.1097/CCM.0b013e3181968fe1.
Results Reference
background
Learn more about this trial
Sigh35 and End-expiratory Occlusion Test (EEOT) for Assessing flUid Responsiveness in Critically Ill Patients Undergoing Pressure Support Ventilation
We'll reach out to this number within 24 hrs